Published in Nanomedicine (Lond) on February 01, 2010
Engineering building blocks for self-assembling protein nanoparticles. Microb Cell Fact (2010) 0.95
Self-assembling, protein-based intracellular bacterial organelles: emerging vehicles for encapsulating, targeting and delivering therapeutical cargoes. Microb Cell Fact (2011) 0.85
Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine. Microb Cell Fact (2011) 0.83
Expanding the recombinant protein quality in Lactococcus lactis. Microb Cell Fact (2014) 0.81
Intracellular CXCR4⁺ cell targeting with T22-empowered protein-only nanoparticles. Int J Nanomedicine (2012) 0.81
Reduction-responsive cross-linked stearyl peptide for effective delivery of plasmid DNA. Int J Nanomedicine (2015) 0.79
Comparative analysis of lentiviral vectors and modular protein nanovectors for traumatic brain injury gene therapy. Mol Ther Methods Clin Dev (2014) 0.78
In Vivo Expansion of Melanoma-Specific T Cells Using Microneedle Arrays Coated with Immune-Polyelectrolyte Multilayers. ACS Biomater Sci Eng (2016) 0.75
Old materials with new tricks: multifunctional open-framework materials. Chem Soc Rev (2007) 3.37
AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinformatics (2007) 3.02
Biomolecular modeling: Goals, problems, perspectives. Angew Chem Int Ed Engl (2006) 2.46
Protein quality in bacterial inclusion bodies. Trends Biotechnol (2006) 2.02
Amyloid-like properties of bacterial inclusion bodies. J Mol Biol (2005) 1.90
Protein folding and conformational stress in microbial cells producing recombinant proteins: a host comparative overview. Microb Cell Fact (2008) 1.89
Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb Cell Fact (2005) 1.79
Microbial factories for recombinant pharmaceuticals. Microb Cell Fact (2009) 1.59
A nanoporous molecular magnet with reversible solvent-induced mechanical and magnetic properties. Nat Mater (2003) 1.50
Exploiting the Burkholderia pseudomallei acute phase antigen BPSL2765 for structure-based epitope discovery/design in structural vaccinology. Chem Biol (2013) 1.45
Assessing equilibration and convergence in biomolecular simulations. Proteins (2002) 1.40
The conformational quality of insoluble recombinant proteins is enhanced at low growth temperatures. Biotechnol Bioeng (2007) 1.34
The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene. Cancer Res (2002) 1.23
Recombinant protein solubility - does more mean better? Nat Biotechnol (2007) 1.21
Localization of functional polypeptides in bacterial inclusion bodies. Appl Environ Microbiol (2006) 1.20
Divergent genetic control of protein solubility and conformational quality in Escherichia coli. J Mol Biol (2007) 1.18
The Key to Solving the Protein-Folding Problem Lies in an Accurate Description of the Denatured State Financial support from the Schweizerischer Nationalfonds (Project no. 21-50929.97) is gratefully acknowledged. Angew Chem Int Ed Engl (2001) 1.18
Role of molecular chaperones in inclusion body formation. FEBS Lett (2003) 1.16
Localization of chaperones DnaK and GroEL in bacterial inclusion bodies. J Bacteriol (2005) 1.12
Two-leg molecular ladders formed by hierarchical self-assembly of an organic radical. J Am Chem Soc (2009) 1.11
Nanotechnology, bionanotechnology and microbial cell factories. Microb Cell Fact (2010) 1.09
Learning about protein solubility from bacterial inclusion bodies. Microb Cell Fact (2009) 1.09
Comparing geometric and kinetic cluster algorithms for molecular simulation data. J Chem Phys (2010) 1.08
Biomedical applications of distally controlled magnetic nanoparticles. Trends Biotechnol (2009) 1.08
Bacterial inclusion bodies: making gold from waste. Trends Biotechnol (2011) 1.07
Configurational entropy elucidates the role of salt-bridge networks in protein thermostability. Protein Sci (2007) 1.06
Unconventional microbial systems for the cost-efficient production of high-quality protein therapeutics. Biotechnol Adv (2012) 1.05
Isolation of cell-free bacterial inclusion bodies. Microb Cell Fact (2010) 1.05
Abundance of the Quorum-Sensing Factor Ax21 in Four Strains of Stenotrophomonas maltophilia Correlates with Mortality Rate in a New Zebrafish Model of Infection. PLoS One (2013) 1.05
Reactivity of superoxide anion radical with a perchlorotriphenylmethyl (trityl) radical. J Phys Chem B (2007) 1.02
Cholesterol induced CTAB micelle-to-vesicle phase transitions. J Colloid Interface Sci (2010) 1.02
MultitaskProtDB: a database of multitasking proteins. Nucleic Acids Res (2013) 1.02
Biological role of bacterial inclusion bodies: a model for amyloid aggregation. FEBS J (2011) 1.01
Microscopic cords, a virulence-related characteristic of Mycobacterium tuberculosis, are also present in nonpathogenic mycobacteria. J Bacteriol (2010) 1.01
Folding of a misfolding-prone beta-galactosidase in absence of DnaK. Biotechnol Bioeng (2005) 1.01
Side effects of chaperone gene co-expression in recombinant protein production. Microb Cell Fact (2010) 1.01
Tunable geometry of bacterial inclusion bodies as substrate materials for tissue engineering. Nanotechnology (2010) 1.00
Molecular dynamics simulations of a reversibly folding beta-heptapeptide in methanol: influence of the treatment of long-range electrostatic interactions. J Phys Chem B (2009) 0.99
Yield, solubility and conformational quality of soluble proteins are not simultaneously favored in recombinant Escherichia coli. Biotechnol Bioeng (2008) 0.99
Can one derive the conformational preference of a beta-peptide from its CD spectrum? J Am Chem Soc (2002) 0.99
Spindle alignment is achieved without rotation after the first cell cycle in Drosophila embryonic neuroblasts. Development (2009) 0.98
Ultrasensitive piezoresistive all-organic flexible thin films. Adv Mater (2010) 0.98
Highly selective chromogenic and redox or fluorescent sensors of Hg2+ in aqueous environment based on 1,4-disubstituted azines. J Am Chem Soc (2005) 0.97
Playing with organic radicals as building blocks for functional molecular materials. Chem Soc Rev (2011) 0.97
Do current sequence analysis algorithms disclose multifunctional (moonlighting) proteins? Bioinformatics (2003) 0.96
Nanostructured bacterial materials for innovative medicines. Trends Microbiol (2010) 0.95
Surface supramolecular organization of a terbium(III) double-decker complex on graphite and its single molecule magnet behavior. J Am Chem Soc (2011) 0.95
Engineering building blocks for self-assembling protein nanoparticles. Microb Cell Fact (2010) 0.95
The chaperone DnaK controls the fractioning of functional protein between soluble and insoluble cell fractions in inclusion body-forming cells. Microb Cell Fact (2006) 0.95
Exploiting antigenic diversity for vaccine design: the chlamydia ArtJ paradigm. J Biol Chem (2010) 0.94
The Functional quality of soluble recombinant polypeptides produced in Escherichia coli is defined by a wide conformational spectrum. Appl Environ Microbiol (2008) 0.94
Do protein-protein interaction databases identify moonlighting proteins? Mol Biosyst (2011) 0.94
Exploiting protein flexibility to predict the location of allosteric sites. BMC Bioinformatics (2012) 0.93
PCOPGene-Net: holistic characterisation of cellular states from microarray data based on continuous and non-continuous analysis of gene-expression relationships. BMC Bioinformatics (2009) 0.92
The rheumatoid arthritis-associated allele HLA-DR10 (DRB1*1001) shares part of its repertoire with HLA-DR1 (DRB1*0101) and HLA-DR4 (DRB*0401). Arthritis Rheum (2008) 0.91
Membrane-active peptides for non-viral gene therapy: making the safest easier. Trends Biotechnol (2008) 0.91
A robust molecular platform for non-volatile memory devices with optical and magnetic responses. Nat Chem (2011) 0.91
The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation. Biomaterials (2010) 0.90
Systems metabolic engineering, industrial biotechnology and microbial cell factories. Microb Cell Fact (2012) 0.90
Thyroglobulin peptides associate in vivo to HLA-DR in autoimmune thyroid glands. J Immunol (2008) 0.89
Overexpression of the immunoreceptor CD300f has a neuroprotective role in a model of acute brain injury. Brain Pathol (2011) 0.89
Velocity dependence of friction and hydrogen bonding effects. Phys Rev Lett (2006) 0.89
Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies. Adv Mater (2012) 0.89
Induction of G(2)/M arrest and inhibition of c-myc and p53 transcription by WP631 in Jurkat T lymphocytes. Biochem Pharmacol (2002) 0.88
Correlation between crystal structure and mobility in organic field-effect transistors based on single crystals of tetrathiafulvalene derivatives. J Am Chem Soc (2004) 0.88
Modular protein engineering for non-viral gene therapy. Trends Biotechnol (2004) 0.88
Bacterial inclusion bodies are cytotoxic in vivo in absence of functional chaperones DnaK or GroEL. J Biotechnol (2005) 0.87
Amyloid-linked cellular toxicity triggered by bacterial inclusion bodies. Biochem Biophys Res Commun (2007) 0.87
Insertional protein engineering for analytical molecular sensing. Microb Cell Fact (2006) 0.87
High-performance single crystal organic field-effect transistors based on two dithiophene-tetrathiafulvalene (DT-TTF) polymorphs. Adv Mater (2010) 0.86
Modular protein engineering in emerging cancer therapies. Curr Pharm Des (2009) 0.86
Multistability in a BEDT-TTF based molecular conductor. J Am Chem Soc (2003) 0.86
Role of the chaperone DnaK in protein solubility and conformational quality in inclusion body-forming Escherichia coli cells. FEMS Microbiol Lett (2007) 0.86
Peptide-mediated DNA condensation for non-viral gene therapy. Biotechnol Adv (2009) 0.86
A new bisintercalating anthracycline with picomolar DNA binding affinity. J Med Chem (2005) 0.86
Influence of growth temperature on the production of antibody Fab fragments in different microbes: a host comparative analysis. Biotechnol Prog (2010) 0.86
A novel approach for designing simple point charge models for liquid water with three interaction sites. J Comput Chem (2003) 0.85
Profiling the allosteric response of an engineered beta-galactosidase to its effector, anti-HIV antibody. Biochem Biophys Res Commun (2004) 0.85
A molecular multiproperty switching array based on the redox behavior of a ferrocenyl polychlorotriphenylmethyl radical. Angew Chem Int Ed Engl (2004) 0.85
Production of functional inclusion bodies in endotoxin-free Escherichia coli. Appl Microbiol Biotechnol (2014) 0.85
Assessing the structural conservation of protein pockets to study functional and allosteric sites: implications for drug discovery. BMC Struct Biol (2010) 0.85
Self-assembling, protein-based intracellular bacterial organelles: emerging vehicles for encapsulating, targeting and delivering therapeutical cargoes. Microb Cell Fact (2011) 0.85
Rehosting of bacterial chaperones for high-quality protein production. Appl Environ Microbiol (2009) 0.84
A compact tetrathiafulvalene-benzothiadiazole dyad and its highly symmetrical charge-transfer salt: ordered donor π-stacks closely bound to their acceptors. Chemistry (2014) 0.84
Post-production protein stability: trouble beyond the cell factory. Microb Cell Fact (2011) 0.84
Polychlorinated trityl radicals for dynamic nuclear polarization: the role of chlorine nuclei. Phys Chem Chem Phys (2010) 0.84
A structure-based strategy for epitope discovery in Burkholderia pseudomallei OppA antigen. Structure (2012) 0.84
Bacterial cell factories for recombinant protein production; expanding the catalogue. Microb Cell Fact (2013) 0.84